Showing results (301-310 of 335) with videos related to
Sort By:
Pageof 34
Leukemia & Lymphoma|June 24, 2008
Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment GroupThomas E Witzig, Susan M Geyer, Paul J Kurtin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disordersIrene M Ghobrial, Thomas M Habermann, Matthew J Maurer, et al.International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancerSteven E Schild, Philip J Stella, Susan M Geyer, et al.Mayo Clinic Proceedings|January 17, 2003
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myelomaShaji Kumar, Morie A Gertz, Angela Dispenzieri, et al.Bone Marrow Transplantation|July 15, 2003
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphomaR Howe, I N M Micallef, D J Inwards, et al.Blood|July 18, 2008
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab eraThomas M Habermann, Sophia S Wang, Matthew J Maurer, et al.Blood|March 1, 2007
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survivalJames R Cerhan, Sophia Wang, Matthew J Maurer, et al.Leukemia|October 31, 2015
Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromesD A Sallman, R Komrokji, C Vaupel, et al.Blood|August 25, 2005
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myelomaS Vincent Rajkumar, Suzanne R Hayman, Martha Q Lacy, et al.Blood|September 30, 2006
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosisAngela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust, et al.Pageof 34